Prashant Mali

24.7k total citations · 9 hit papers
96 papers, 17.8k citations indexed

About

Prashant Mali is a scholar working on Molecular Biology, Biomedical Engineering and Genetics. According to data from OpenAlex, Prashant Mali has authored 96 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 10 papers in Biomedical Engineering and 9 papers in Genetics. Recurrent topics in Prashant Mali's work include CRISPR and Genetic Engineering (52 papers), Pluripotent Stem Cells Research (30 papers) and RNA and protein synthesis mechanisms (13 papers). Prashant Mali is often cited by papers focused on CRISPR and Genetic Engineering (52 papers), Pluripotent Stem Cells Research (30 papers) and RNA and protein synthesis mechanisms (13 papers). Prashant Mali collaborates with scholars based in United States, China and Singapore. Prashant Mali's co-authors include George M. Church, Kevin M. Esvelt, John Aach, James J. DiCarlo, Julie E. Norville, Luhan Yang, Marc Güell, Mark Moosburner, Linzhao Cheng and Xavier Rios and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Prashant Mali

93 papers receiving 17.5k citations

Hit Papers

RNA-Guided Human Genome Engineering via Cas9 2013 2026 2017 2021 2013 2013 2013 2013 2014 2.0k 4.0k 6.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RNA-Guided Human Genome Engineering via Cas9
    2013 7.0k citations Prashant Mali, Luhan Yang et al. Science profile →
  2. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
    2013 1.4k citations Prashant Mali, John Aach et al. Nature Biotechnology profile →
  3. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems
    2013 1.2k citations James J. DiCarlo, Julie E. Norville et al. profile →
  4. Cas9 as a versatile tool for engineering biology
    2013 881 citations Prashant Mali, Kevin M. Esvelt et al. Nature Methods profile →
  5. Highly Multiplexed Subcellular RNA Sequencing in Situ
    2014 693 citations Reza Kalhor, Prashant Mali et al. Science profile →
  6. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
    2013 648 citations Kevin M. Esvelt, Prashant Mali et al. Nature Methods profile →
  7. A multifunctional AAV–CRISPR–Cas9 and its host response
    2016 479 citations Wei Leong Chew, Prashant Mali et al. Nature Methods profile →
  8. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs
    2022 116 citations Dhruva Katrekar, Dario Meluzzi et al. Nature Biotechnology profile →
  9. RNA editing: Expanding the potential of RNA therapeutics
    2023 93 citations Sami Nourreddine, Dhruva Katrekar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prashant Mali United States 40 16.4k 3.3k 1.4k 1.1k 1.1k 96 17.8k
Charles A. Gersbach United States 53 13.5k 0.8× 3.5k 1.1× 1.4k 1.0× 976 0.9× 853 0.8× 130 15.6k
Lei S. Qi United States 55 19.9k 1.2× 3.9k 1.2× 1.8k 1.2× 1.3k 1.2× 1.4k 1.3× 186 22.2k
Le Cong United States 34 17.5k 1.1× 4.1k 1.2× 2.1k 1.4× 1.3k 1.2× 1.1k 1.1× 60 20.7k
Naomi Habib United States 20 15.6k 0.9× 3.2k 1.0× 1.6k 1.1× 894 0.8× 957 0.9× 34 18.0k
Wenyan Jiang China 19 13.7k 0.8× 3.3k 1.0× 1.6k 1.1× 1.0k 1.0× 824 0.8× 39 15.5k
Luke A. Gilbert United States 38 16.2k 1.0× 2.8k 0.8× 1.3k 0.9× 941 0.9× 1.2k 1.1× 68 18.0k
Xuebing Wu United States 25 18.8k 1.1× 4.4k 1.3× 2.1k 1.5× 1.4k 1.3× 1.3k 1.2× 35 20.7k
Silvana Konermann United States 18 15.2k 0.9× 2.7k 0.8× 1.7k 1.2× 1.5k 1.4× 1.2k 1.1× 26 16.3k
David Cox United States 27 20.5k 1.2× 4.6k 1.4× 2.4k 1.6× 1.7k 1.6× 1.1k 1.1× 81 25.2k
Robert P. J. Barretto United States 10 10.4k 0.6× 2.4k 0.7× 1.3k 0.9× 727 0.7× 689 0.7× 12 12.6k

Countries citing papers authored by Prashant Mali

Since Specialization
Citations

This map shows the geographic impact of Prashant Mali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashant Mali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashant Mali more than expected).

Fields of papers citing papers by Prashant Mali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prashant Mali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashant Mali. The network helps show where Prashant Mali may publish in the future.

Co-authorship network of co-authors of Prashant Mali

This figure shows the co-authorship network connecting the top 25 collaborators of Prashant Mali. A scholar is included among the top collaborators of Prashant Mali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prashant Mali. Prashant Mali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burleigh, Stephen, Robert Fragoza, Yue Jiang, et al.. (2025). An engineered U7 small nuclear RNA scaffold greatly increases ADAR-mediated programmable RNA base editing. Nature Communications. 16(1). 4860–4860. 3 indexed citations
2.
Koshizuka, Keiichi, Xingyu Wu, Kuniaki Sato, et al.. (2025). Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer. Cancer Research. 85(16). 3032–3051. 1 indexed citations
3.
Fong, Samson, Brent M. Kuenzi, John J. Y. Lee, et al.. (2024). A multilineage screen identifies actionable synthetic lethal interactions in human cancers. Nature Genetics. 57(1). 154–164. 5 indexed citations
4.
Lyu, Wei, Sami Nourreddine, Michael Z. Tong, et al.. (2024). Charting and probing the activity of ADARs in human development and cell-fate specification. Nature Communications. 15(1). 9818–9818. 2 indexed citations
5.
Allevato, Michael M., Keiichi Koshizuka, Daniela Nachmanson, et al.. (2024). A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death. Cancer Letters. 598. 217089–217089. 8 indexed citations
6.
Tong, Michael Z., Nathan Palmer, Aditya Kumar, et al.. (2024). Robust genome and cell engineering via in vitro and in situ circularized RNAs. Nature Biomedical Engineering. 9(1). 109–126. 15 indexed citations
7.
Ford, Kyle, Samson Fong, Nongluk Plongthongkum, et al.. (2023). Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation. Scientific Reports. 13(1). 7678–7678. 4 indexed citations
8.
Katrekar, Dhruva, et al.. (2022). Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nature Biotechnology. 40(6). 938–945. 116 indexed citations breakdown →
9.
Moreno, Ana M., Fernando Alemán, Matthew A. Hunt, et al.. (2021). Long-lasting analgesia via targeted in situ repression of Na V 1.7 in mice. Science Translational Medicine. 13(584). 80 indexed citations
10.
Paradis, Justine S., Robert Saddawi‐Konefka, Simone Lubrano, et al.. (2021). Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ -Driven Uveal Melanoma. Clinical Cancer Research. 27(11). 3190–3200. 54 indexed citations
11.
Larson, Jon D., Kyle Ford, Daniella McDonald, et al.. (2021). Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures. Biomaterials. 280. 121276–121276. 6 indexed citations
12.
McDonald, Daniella, Yan Wu, Udit Parekh, et al.. (2020). Defining the Teratoma as a Model for Multi-lineage Human Development. Cell. 183(5). 1402–1419.e18. 31 indexed citations
13.
Rocca, Céline J., et al.. (2020). CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia. Molecular Therapy — Methods & Clinical Development. 17. 1026–1036. 23 indexed citations
14.
Katrekar, Dhruva, et al.. (2019). In vivo RNA editing of point mutations via RNA-guided adenosine deaminases. Nature Methods. 16(3). 239–242. 148 indexed citations
15.
Kalhor, Reza, Kian Kalhor, Kathleen Leeper, et al.. (2018). Developmental barcoding of whole mouse via homing CRISPR. Science. 361(6405). 226 indexed citations
16.
Kalhor, Reza, Prashant Mali, & George M. Church. (2016). Rapidly evolving homing CRISPR barcodes. Nature Methods. 14(2). 195–200. 147 indexed citations
17.
Mali, Prashant, et al.. (2015). Rare Case of Vasculitis of the Hepatic Artery. Clinical Medicine & Research. 13(3-4). 169–172. 4 indexed citations
18.
Mali, Prashant, Luhan Yang, Kevin M. Esvelt, et al.. (2013). RNA-Guided Human Genome Engineering via Cas9. Science. 339(6121). 823–826. 6968 indexed citations breakdown →
19.
Zou, Chunlin, Bin-Kuan Chou, Sarah N. Dowey, et al.. (2012). Efficient Derivation and Genetic Modifications of Human Pluripotent Stem Cells on Engineered Human Feeder Cell Lines. Stem Cells and Development. 21(12). 2298–2311. 27 indexed citations
20.
Ye, Zhaohui, Huichun Zhan, Prashant Mali, et al.. (2009). Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 114(27). 5473–5480. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles A. Gersbach Breakdown of academic impact, for papers by Lei S. Qi Breakdown of academic impact, for papers by Le Cong Breakdown of academic impact, for papers by Naomi Habib Breakdown of academic impact, for papers by Wenyan Jiang Breakdown of academic impact, for papers by Luke A. Gilbert Breakdown of academic impact, for papers by Xuebing Wu Breakdown of academic impact, for papers by Silvana Konermann Breakdown of academic impact, for papers by David Cox Breakdown of academic impact, for papers by Robert P. J. Barretto
Rankless by CCL
2026